Cathryn Bock
Position Title
Associate Professor, Oncology
Office Location
Mid-Med Lofts87 E Canfield
Detroit, MI 48201
Mailing Address
Office Phone
313-578-4203Office Fax
313-578-4306Degrees
MPH, PhDEducation Training
Education
(1998-2002) PhD, Epidemiological Science, University of Michigan, Ann Arbor, MI
(1998-2001) Trainee, NHGRI Genome Science Training Grant, (PIs: Boehnke, Meisler) University of Michigan, Ann Arbor, MI
(1996-1998) MPH, Health Behavior & Health Education, Interdepartmental Concentration in Public Health Genetics: School of Public Health, University of Michigan, Ann Arbor, MI
(1984-1988) B.A. (magna cum laude), Psychology: Wheaton College, Norton, MA
Postgraduate Training
(2003-2004) Postdoctoral Research Fellow, Wayne State University and Barbara Ann Karmanos Cancer Institute, Detroit, MI
Professional Experience
Faculty Appointments
(2013-Present) Associate Professor, Department of Oncology, Wayne State University School of Medicine, Detroit, MI
(2010-2013) Assistant Professor, Department of Oncology, Wayne State University School of Medicine, Detroit, MI
(2005-2010) Assistant Professor, Department of Internal Medicine, Wayne State University School of Medicine, Detroit, MI
Major Professional Societies
AACR
Courses taught
FPH 7240: Introduction to Epidemiology
Research Interests
Dr. Bock's primary research interest is focused on explaining the disparately high rates of prostate cancer incidence, aggressiveness, and mortality among African American men in order to inform measures that could reduce these disparities. Her focus is primarily on genetic and environmental risk factors and their interactions. She is the faculty advisor for Cancer Prevention, Screening, and Connections to Care for the Karmanos Cancer Institute office of Community Outreach and Engagemen. She was the PI of a DOD-funded study examining the role of microRNAs in prostate cancer risk, aggressiveness, and PSA relapse in a cohort of African American and European American men recently diagnosed with prostate cancer at the time of study entry. She is examining both plasma levels of candidate microRNAs as well as genetic variation in genes encoding micrRNAs as well as genes involved in microRNA regulation. She is also interested in admixture mapping as a method for disease susceptibility gene identification, and has completed a prostate cancer admixture mapping project in a sample of African American men. Dr. Bock is affiliated with the Metropolitan Detroit Cancer Surveillance System (MDCSS), and collaborates with investigators using MDCSS data on a wide variety of cancer research questions.